Literature DB >> 22001409

Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.

Pei-Yao Liu1, Tsai-Yuan Hsieh, Shu-Ting Liu, Yung-Lung Chang, Wei-Shiang Lin, Wei-Ming Wang, Shih-Ming Huang.   

Abstract

Zac1 functions as both a transcription factor and a transcriptional cofactor for p53, nuclear receptors (NRs) and NR coactivators. Zac1 might also act as a transcriptional repressor via the recruitment of histone deacetylase 1 (HDAC1). The ability of Zac1 to interact directly with GC-specific elements indicates that Zac1 possibly binds to Sp1-responsive elements. In the present study, our data show that Zac1 is able to interact directly with the Sp1-responsive element in the p21(WAF1/Cip1) gene promoter and enhance the transactivation activity of Sp1 through direct physical interaction. Our data further demonstrate that Zac1 might enhance Sp1-specific promoter activity by interacting with the Sp1-responsive element, affecting the transactivation activity of Sp1 via a protein-protein interaction, or competing the HDAC1 protein away from the pre-existing Sp1/HDAC1 complex. Finally, the synergistic regulation of p21(WAF1/Cip1) gene expression by Zac1 and Sp1 is mediated by endogenous p53 protein and p53-responsive elements in HeLa cells. Our work suggests that Zac1 might serve as an Sp1-like protein that directly interacts with the Sp1-responsive element to oligomerize with and/or to coactivate Sp1.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001409     DOI: 10.1016/j.yexcr.2011.09.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  PLAGL1: an important player in diverse pathological processes.

Authors:  Ana F Vega-Benedetti; Cinthia Saucedo; Patrizia Zavattari; Roberta Vanni; José L Zugaza; Luis Antonio Parada
Journal:  J Appl Genet       Date:  2016-06-16       Impact factor: 3.240

2.  Zac1 regulates cell cycle arrest in neuronal progenitors via Tcf4.

Authors:  Udo Schmidt-Edelkraut; Guillaume Daniel; Anke Hoffmann; Dietmar Spengler
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

Review 3.  The p53 circuit board.

Authors:  Kelly D Sullivan; Corrie L Gallant-Behm; Ryan E Henry; Jean-Luc Fraikin; Joaquín M Espinosa
Journal:  Biochim Biophys Acta       Date:  2012-02-07

Review 4.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

5.  Cell-type and transcription factor specific enrichment of transcriptional cofactor motifs in ENCODE ChIP-seq data.

Authors:  Chin Goi; Peter Little; Chao Xie
Journal:  BMC Genomics       Date:  2013-10-16       Impact factor: 3.969

6.  PLAGL1 gene function during hepatoma cells proliferation.

Authors:  Ana F Vega-Benedetti; Cinthia N Saucedo; Patrizia Zavattari; Roberta Vanni; Felix Royo; Francisco Llavero; José L Zugaza; Luis A Parada
Journal:  Oncotarget       Date:  2018-08-28

7.  Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells.

Authors:  Chi-Kang Lin; Shu-Ting Liu; Cheng-Chang Chang; Shih-Ming Huang
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

8.  Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds.

Authors:  Marsha Crochiere; Trinayan Kashyap; Ori Kalid; Sharon Shechter; Boris Klebanov; William Senapedis; Jean-Richard Saint-Martin; Yosef Landesman
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

9.  Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7.

Authors:  Yu-Wen Chu; Shu-Ting Liu; Hsiao-Chun Cheng; Shih-Ming Huang; Yung-Lung Chang; Chien-Ping Chiang; Ying-Chun Liu; Wei-Ming Wang
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.